Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients
| Image |  |
|---|---|
| Description | scientific article published on 22 January 2020 |
| Author/s | |
| Publication date | January 22, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |